SML2065
Mequitazine
≥98% (HPLC)
别名:
10-(1-Azabicyclo[2.2.2]oct-3-ylmethyl)-10H-phenothiazine, 10-(3-quinuclidinylmethyl) phenothiazine, LM 209, NSC 303612
SMILES string
S1c2c(cccc2)N(c5c1cccc5)CC3C4CCN(C3)CC4
InChI
1S/C20H22N2S/c1-3-7-19-17(5-1)22(18-6-2-4-8-20(18)23-19)14-16-13-21-11-9-15(16)10-12-21/h1-8,15-16H,9-14H2
InChI key
HOKDBMAJZXIPGC-UHFFFAOYSA-N
assay
≥98% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
−20°C
Biochem/physiol Actions
Mequitazine is a potent, nonsedative, long-acting and selective H1 histamine receptor antagonist. Mequitazine exhibits weak anticholinergic activity.
potent, nonsedative, long-acting and selective H1 histamine receptor antagonist
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Oral
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
I Martinez-Mir et al.
The Journal of pharmacy and pharmacology, 40(9), 655-656 (1988-09-01)
The antihistamine and anticholinergic properties of mequitazine have been investigated and compared with those of clemizole. Both mequitazine and clemizole antagonized the effect of histamine in guinea-pig ileum competitively, the pA2 values calculated by Schild plot were 9.95 +/- 0.44
K Nakamura et al.
The Journal of pharmacology and experimental therapeutics, 284(2), 437-442 (1998-03-07)
Mequitazine [10-(3-quinuclidinylmethyl) phenothiazine] is a long-acting and selective histamine H1-receptor antagonist that is mainly biotransformed by human liver microsomes to yield hydroxylated and S-oxidized metabolites. Mequitazine hydroxylase was inhibited by propranolol and quinidine. Lineweaver-Burk plots for the hydroxylation and the
Tatsuya Isomura et al.
PloS one, 9(12), e114336-e114336 (2014-12-17)
Second-generation antihistamines (AHs) have, in general, fewer sedative effects than the first-generation. However, important inter-drug differences remain in the degree of cognitive and/or psychomotor impairment. The extent to which a particular compound causes disruption can be conveniently compared, to all
Shigeru Hishinuma et al.
Journal of pharmacological sciences, 107(1), 66-79 (2008-05-01)
We evaluated changes in the binding properties of sedative and non-sedative histamine H1-receptor antagonists induced by internalization of H1 receptors in intact human U373 MG astrocytoma cells. Internalization of H1 receptors was induced without their degradation by treatment with 0.1
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持